Evidence Reviews
How to Read a Peptide-Medicine Trial: The SELECT Example
Use SELECT to read a peptide-medicine trial’s population, comparator, endpoints, follow-up and subgroup analysis without overstating the evidence.
Read articleArticle category
Evidence Reviews
Reading findings alongside uncertainty and limitations.
Evidence Reviews
Peptide Reference Standards and the Limits of Comparison
How peptide reference materials support calibration and comparison, with NIST definitions and an OSPP study showing the scope of analytical claims.
Read article
Evidence Reviews
Peptide Quality Tests Are Not Interchangeable: Identity, Endotoxin, and Sterility
FDA guidance on recombinant endotoxin methods and sterility testing shows why peptide quality claims must stay tied to specific records.
Read article
Evidence Reviews
The Model and Timepoint Belong in a Peptide Study’s Conclusion
A focused reading of an animal peptide study shows how to keep the model, assessment time and source type visible in scientific summaries.
Read article
Evidence Reviews
From Cells to Clinical Evidence: What Peptide Studies in Different Models Can Establish
Examine why isolated in vitro peptide mechanisms rarely guarantee systemic results, and how to classify evidence from cell models to controlled human trials.
Read article
Evidence Reviews
Using ARRIVE Reporting Standards to Evaluate Experimental Rigor in Animal Peptide Literature
Learn how to read peptide research papers by identifying exact study models, understanding laboratory limits, and separating in vitro data from broad conclusions.
Read article
Evidence Reviews
Why Standard Peptide Nomenclature Fails to Capture the Full Physical Reality of Lab Compounds
A scientific review of how sequence nomenclature, structural modifications, and counterions affect actual peptide compound identity and laboratory documentation.
Read article
Evidence Reviews
Using Orthogonal Testing Methods to Separate Target Peptides from Nearly Identical Impurities
Learn why a single analytical metric cannot establish complete peptide identity or purity, and how chromatography and mass spectrometry serve distinct roles.
Read article
Evidence Reviews
Measuring Quantitative Outcomes in Preclinical Peptide Models with Flow Cytometry and ELISA
Learn how researchers distinguish proposed pathways from measured laboratory outcomes in peptide research, utilizing in vitro and animal study models.
Read article
Evidence Reviews
The Peptide Evidence Ladder: What Each Study Model Demonstrates
Learn how peptide research progresses through experimental models. We examine the critical gap between preclinical mechanisms and human clinical trials.
Read article
Evidence Reviews
Systematic Review of BPC-157 Reveals Vast Gap Between Laboratory Studies and Human Clinical Data
This BPC-157 evidence profile separates preclinical laboratory mechanisms from human data, detailing the current absence of controlled clinical efficacy trials.
Read article
Evidence Reviews
The High Translational Risk of Mistaking Preclinical Peptide Signals for Human Clinical Proof
Learn to interpret peptide research by separating experimental models from clinical outcomes. Apply this 9-step evaluation framework to assess study strength.
Read articleA clearer starting point
Keep the question going.
Find a research path, read a guide or take a closer look at a laboratory report.